View on Pubmed.gov 5309489 View on doi.org
Future influenza vaccines and the use of genetic recombinants.
Abstract
Genetic recombination of influenza viruses provides the possibility of immediate reassortment and combination of genes and gene products in a single step. Thus, genetic variants with desirable attributes for vaccine production can be produced by deliberate genetic manipulation of viruses rather than by the empirical "hit or miss" methods of the past. Recombination of a high-yield laboratory strain (A0/PR/8) with a low-yield Hong Kong virus (Aichi strain) produced a high-yield recombinant virus (X-31) of Hong Kong antigenicity suitable for vaccine production. It is proposed that a prefabricated "library" of recombinants might anticipate the mutations which may arise in the future and also that live virus vaccines of greater stability may be produced by recombination of new and old viruses.
References
Virology. 1966 Nov;30(3):493-501
Science. 1968 Apr 5;160(3823):74-6
Proc Natl Acad Sci U S A. 1969 Jun;63(2):326-33
J Exp Med. 1960 Mar 1;111:387-406
Cited by 388 citations (total)
Historical Article Journal Article Research Support, N.I.H., Extramural Review
Challenges of Making Effective Influenza Vaccines.
Electronic publication date July 23, 2021
Sigrid Gouma [...] Scott E Hensley et al.
Seasonal influenza vaccines prevent influenza-related illnesses, hospitalizations, and deaths. However, these vaccines are not as effective as other viral vaccines,...
Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia.
Electronic publication date February 1, 1993
S R Carding [...] P C Doherty et al.
The patterns of cytokine mRNA expression in mice with primary or secondary influenza pneumonia have been assessed by in situ...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •